Zurich, Switzerland

Matthias Steger

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • St. Gallen, CH (2010)
  • Zürich, CH (2006 - 2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Introduction

Matthias Steger is a prominent inventor based in Zurich, Switzerland, recognized for his substantial contributions to the field of pharmaceuticals. With a total of three patents to his name, Steger has focused on developing novel compounds that address significant medical needs.

Latest Patents

Steger's latest innovations include two significant patents. The first is for "2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as CRTH2 antagonists." This invention pertains to the application of these derivatives as potent antagonists for the chemoattractant receptor-homologous molecule expressed on Th2 cells, aiming to treat prostaglandin-mediated diseases. Furthermore, it includes details on the pharmaceutical compositions and processes involved in their preparation.

The second patent pertains to "guanidine derivatives and their use as neuropeptide FF receptor antagonists." This invention describes guanidine derivatives with a specific formula, which can be used to develop treatments for various conditions including pain management, withdrawal symptoms in dependence situations, and regulation of insulin excretion among others. These compounds offer potential therapeutic avenues for a range of medical challenges.

Career Highlights

Matthias Steger works at Actelion Pharmaceuticals Ltd., a leading company in innovative medicines for high unmet medical needs. His research has significantly advanced the understanding and treatment options available for complex medical conditions.

Collaborations

During his career, Steger has collaborated with esteemed colleagues such as Kurt Hilpert and Thomas Giller. These collaborations have facilitated the exchange of ideas and expertise, enhancing the innovation process within the pharmaceutical sector.

Conclusion

With his innovative patents and contributions to pharmaceutical science, Matthias Steger continues to make strides in addressing critical health issues. His work exemplifies the vital role of inventors in advancing medical treatments and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…